|
| Name
| Source |
Route |
Yrs. on Market |
| Cenestin |
soy & yam |
oral |
2 |
| Climara® |
yam |
transdermal |
5 |
| Estrace® |
soy & yam |
oral |
25 |
| Estraderm® |
plant inc. yam |
transdermal |
14 |
| Estring® |
yam |
vaginal |
5 |
| Estratab® |
plant inc. soy |
oral |
23+ |
| Menest® |
yam |
|
|
| Ogen® |
plant inc. yam |
oral |
46+ |
| Ortho-Dienestrol®
synthetic |
vaginal |
26+ |
| Ortho-Est® |
yam |
oral |
7 |
| Premarin® |
pregnant mare's urine |
oral
vaginal |
59
26+ |
| Vivelle |
yam |
transdermal |
5 |
| Promensil® |
red clover |
oral |
2 |
| Remifemin |
soy ® yam |
oral |
40 |
| Progesterone |
soy & yam< |
oral ® transdermal |
22 |
| Estriol® |
yam |
oral ® transdermal |
40+ |
| Tri-Est |
yam |
oral ® transdermal |
20 |
Known comparable dosages to Premarin 0.625 mg for menopausal flashes have generally been determined to be: Estrace
1.0 mg ~ Estraderm 50 mcg ~ Ogen 0.625 mg (0.75 mg if measured as "estropipate"). These drugs are also approved for osteoporosis in the same
dosages, except Estrace, where .05 mg is sufficient.
Disclaimer: These charts are intended for information only and no part of their contents should be construed as medical advice, diagnosis,
recommendation or endorsement by Conscious Choice Magazine.
|
